Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,626,183
  • Shares Outstanding, K 48,462
  • Annual Sales, $ 270,600 K
  • Annual Income, $ -239,240 K
  • EBIT $ -300 M
  • EBITDA $ -290 M
  • 60-Month Beta 1.26
  • Price/Sales 16.56
  • Price/Cash Flow N/A
  • Price/Book 47.27

Options Overview Details

View History
  • Implied Volatility 80.53% ( +2.24%)
  • Historical Volatility 41.99%
  • IV Percentile 97%
  • IV Rank 89.65%
  • IV High 86.15% on 11/08/24
  • IV Low 31.91% on 08/23/24
  • Put/Call Vol Ratio 2.40
  • Today's Volume 364
  • Volume Avg (30-Day) 713
  • Put/Call OI Ratio 1.04
  • Today's Open Interest 37,686
  • Open Int (30-Day) 35,971

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.99
  • Number of Estimates 9
  • High Estimate -0.46
  • Low Estimate -1.37
  • Prior Year -0.73
  • Growth Rate Est. (year over year) -35.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.06 +9.92%
on 11/05/24
105.00 -9.90%
on 11/13/24
+1.25 (+1.34%)
since 10/18/24
3-Month
80.85 +17.01%
on 10/10/24
105.00 -9.90%
on 11/13/24
+6.44 (+7.30%)
since 08/20/24
52-Week
58.61 +61.41%
on 11/21/23
105.00 -9.90%
on 11/13/24
+34.56 (+57.56%)
since 11/20/23

Most Recent Stories

More News
Axsome's Q3 Earnings Beat, Auvelity Drives Sales Growth, Stock Up

Axsome Therapeutics, Inc. AXSM incurred an adjusted loss of $1.34 per share in the third quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of $1.38. The company had incurred a loss...

JAZZ : 119.24 (+2.07%)
CSTL : 28.45 (-1.45%)
ANIP : 55.10 (-1.06%)
AXSM : 94.60 (-0.90%)
Axsome Therapeutics (AXSM) Q3 2024 Earnings Call Transcript

AXSM earnings call for the period ending September 30, 2024.

AXSM : 94.60 (-0.90%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 4.76 (-3.64%)
STIM : 0.8025 (+6.26%)
PGY : 8.77 (+1.74%)
QSI : 1.3900 (+119.59%)
MNOV : 1.9500 (+2.63%)
AXSM : 94.60 (-0.90%)
VSAT : 6.93 (+1.46%)
ZS : 200.94 (-1.67%)
BTM : 1.98 (-2.94%)
RVPH : 1.2150 (-3.57%)
SPY : 590.50 (+0.03%)
XBI : 94.01 (+0.90%)
Axsome: Q3 Earnings Snapshot

Axsome: Q3 Earnings Snapshot

AXSM : 94.60 (-0.90%)
Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

AXSM : 94.60 (-0.90%)
Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024

AXSM : 94.60 (-0.90%)
Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024

AXSM : 94.60 (-0.90%)
3 Bargain Stocks to Buy in a Market That's Priced for Perfection

Yes, bargains can still be found in the stock market.

CRSP : 47.26 (+0.62%)
BRK.A : 703,300.00 (-0.09%)
BRK.B : 468.83 (-0.01%)
PFE : 24.94 (-0.64%)
AXSM : 94.60 (-0.90%)
Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12

AXSM : 94.60 (-0.90%)
Intra-Cellular's Caplyta Sales Boost Revenues, Dependence a Woe

Intra-Cellular ITCI is focused on discovering, developing and commercializing small molecule drugs for treating neuropsychiatric and neurological disorders. The company currently has only one marketed...

ITCI : 85.64 (+2.75%)
XENE : 39.34 (+1.26%)
AXSM : 94.60 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

See More

Key Turning Points

3rd Resistance Point 98.95
2nd Resistance Point 97.93
1st Resistance Point 96.27
Last Price 94.60
1st Support Level 93.59
2nd Support Level 92.57
3rd Support Level 90.91

See More

52-Week High 105.00
Last Price 94.60
Fibonacci 61.8% 87.28
Fibonacci 50% 81.81
Fibonacci 38.2% 76.33
52-Week Low 58.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar